The University of Southampton
University of Southampton Institutional Repository

Brief psychosocial therapy for the treatment of agitation in Alzheimer disease (the CALM-AD trial)

Ballard, Clive, Brown, Richard, Fossey, Jane, Douglas, Simon, Bradley, Paul, Hancock, Judith, James, Ian A, Juszczak, Edmund, Bentham, Peter, Burns, Alistair, Lindesay, James, Jacoby, Robin, O'Brien, John, Bullock, Roger, Johnson, Tony, Holmes, Clive and Howard, Robert (2009) Brief psychosocial therapy for the treatment of agitation in Alzheimer disease (the CALM-AD trial) American Journal of Geriatric Psychiatry, 17, (9), pp. 726-33. (doi:10.1097/JGP.0b013e3181b0f8c0). (PMID:19700946).

Record type: Article

Abstract

Background: good practice guidelines state that a psychological intervention should usually precede pharmacotherapy, but there are no data evaluating the feasibility of psychological interventions used in this way.

Methods: at the first stage of a randomized blinded placebo-controlled trial, 318 patients with Alzheimer disease (AD) with clinically significant agitated behavior were treated in an open design with a psychological intervention (brief psychosocial therapy [BPST]) for 4 weeks, preceding randomization to pharmacotherapy. The therapy involved social interaction, personalized music, or removal of environmental triggers.

Results: overall, 318 patients with AD completed BPST with an improvement of 5.6 points on the total Cohen-Mansfield Agitation Inventory (CMAI; mean [SD], 63.3 [16.0] to 57.7 [18.4], t = 4.8, df = 317, p < 0.0001). Therapy worksheets were completed in six of the eight centers, with the key elements of the intervention delivered according to the manual for >95% of patients. More detailed evaluation of outcome was completed for the 198 patients with AD from these centers, who experienced a mean improvement of 6.6 points on the total CMAI (mean [SD], 62.2 [14.3] to 55.6 [15.8], t = 6.5, df = 197, p < 0.0001). Overall, 43% of participants achieved a 30% improvement in their level of agitation.

Conclusion: the specific attributable benefits of BPST cannot be determined from an open trial. However, the BPST therapy was feasible and was successfully delivered according to an operationalized manual. The encouraging outcome indicates the need for a randomized controlled trial of BPST.

Full text not available from this repository.

More information

Published date: September 2009

Identifiers

Local EPrints ID: 152271
URI: http://eprints.soton.ac.uk/id/eprint/152271
PURE UUID: 71592d79-881a-4b84-9f72-c1905dd9e758

Catalogue record

Date deposited: 14 May 2010 09:03
Last modified: 18 Jul 2017 12:54

Export record

Altmetrics

Contributors

Author: Clive Ballard
Author: Richard Brown
Author: Jane Fossey
Author: Simon Douglas
Author: Paul Bradley
Author: Judith Hancock
Author: Ian A James
Author: Edmund Juszczak
Author: Peter Bentham
Author: Alistair Burns
Author: James Lindesay
Author: Robin Jacoby
Author: John O'Brien
Author: Roger Bullock
Author: Tony Johnson
Author: Clive Holmes
Author: Robert Howard

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×